Krystal Biotech (KRYS) Return on Sales (2023 - 2026)

Krystal Biotech (KRYS) has 4 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), and the FY2025 full-year result was 0.01%, changed 0.0% from the prior year.
• Return on Sales steadied at 0.0% in Q1 2026, from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.09% in Q3 2023 to a low of 0.0% in Q1 2024.
• A 4-year average of 0.01% and a median of 0.0% in 2025 frame the typical range for Return on Sales.
• Peak annual rise in Return on Sales reached 0 bps in 2024, while the deepest fall reached 9 bps in 2024.
• Tracing KRYS's Return on Sales over 4 years: stood at 0.0% in 2023, then surged by 142 bps to 0.0% in 2024, then slipped by 4 bps to 0.0% in 2025, then climbed by 0 bps to 0.0% in 2026.
• Business Quant data shows KRYS's Return on Sales at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.01% in Q3 2025.